Key terms
About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NRXP news
Yesterday
5:22pm ET
NRX Pharmaceuticals Announces Reverse Stock Split
Mar 21
5:22pm ET
NRX Pharmaceuticals Shareholders Approve Potential Reverse Split
Mar 18
8:36am ET
NRx Pharmaceuticals announces plan to distribute shares of HOPE Therapeutics
Mar 12
7:51am ET
NRx Pharmaceuticals initiates strategy to combat short sales
Mar 11
8:35am ET
NRx Pharmaceuticals completes MOU with distribution partners for HTX-100
Mar 04
8:37am ET
NRx Pharmaceuticals: Last patient, last visit in Phase 2b/3 trial of NRX-101
Mar 01
8:35am ET
NRx Pharmaceuticals announces $1M purchase agreement
Feb 26
4:03pm ET
NRx Pharmaceuticals announces common stock offering, no amount given
Feb 26
8:35am ET
NRx Pharmaceuticals launches HOPE Therapeutics at BIO Conference
Feb 14
4:45pm ET
NRX Pharmaceuticals Amends Repayment Terms with Streeterville Capital
Feb 12
8:33am ET
NRx Pharmaceuticals receives $5M milestone payment
Feb 09
8:33am ET
NRx reports comments from its partner Lotus on its recent financial filing
Feb 05
7:04am ET
NRx Pharmaceuticals announces incorporation of Hope Therapeutics
Jan 22
2:09pm ET
Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100
Jan 22
6:53am ET
NRx Pharmaceuticals completes enrollment in NRX-101 study
Jan 17
7:02am ET
NRx Pharmaceuticals granted request for transfer of listing to Nasdaq Capital
Jan 02
6:49am ET
NRx Pharmaceuticals announces plan to regain compliance with Nasdaq
No recent news articles are available for NRXP
No recent press releases are available for NRXP
NRXP Financials
Key terms
Ad Feedback
NRXP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NRXP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range